Esophageal cancer affects the esophagus lining, causing swallowing difficulty and chest pain. Learn what symptoms to look for ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

During a live event, Sumanta K. Pal, MD, discusses the efficacy and safety findings from the CheckMate 274 trial of adjuvant ...

The Harrison resident, diagnosed with esophageal cancer in 2021, worried about looking his best for his son’s wedding. “I was all worked up,” said Hines, 60, retired after 30 years with the ...

Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient, surgically resectable endometrial cancer.

The primary endpoint was progression-free survival (PFS; nivolumab/ipilimumab vs chemotherapy ... repair deficient metastatic colorectal cancer,” said Dana Walker, MD, MSCE, vice president ...

A total of 495 patients were randomized to receive either “subcutaneous nivolumab ... lung cancer; head and neck squamous cell carcinoma; colorectal cancer, hepatocellular carcinoma, esophageal ...

"The positive CHMP opinion is an important step forward in the evolution of immuno-oncology and in the potential of subcutaneous nivolumab to help transform the lives of people living with cancer ...